NCT06641427

Brief Summary

The association between SLE and development of of gastrointestinal bleeding

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for all trials

Timeline
16mo left

Started Oct 2024

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Oct 2024Sep 2027

Study Start

First participant enrolled

October 1, 2024

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

October 12, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

October 15, 2024

Status Verified

October 1, 2024

Enrollment Period

2.9 years

First QC Date

October 12, 2024

Last Update Submit

October 12, 2024

Conditions

Systemic Lupus Erythematosus

Outcome Measures

Primary Outcomes (1)

  • review diferrent aspects and causes of GIT bleeding in SLE patient

    in this study we will review diferrent aspects and causes of GIT bleeding in SLE patient

    baseline

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient more than 18 years old classified as systemic lupus erythematosus Both sex with no other clinical conditions that causes gastrointestinal bleeding as ulcerative colitis \& chrons

You may qualify if:

  • \- Patient more than 18 years old classified as systemic lupus erythematosus Both sex

You may not qualify if:

  • Patients with other clinical conditions that causes gastrointestinal bleeding as ulcerative colitis \& chrons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lupus Erythematosus, Systemic

Condition Hierarchy (Ancestors)

Connective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Zine alabden Ahmed Said

    Assiut University

    PRINCIPAL INVESTIGATOR

  • Eman Mohamed Ebrahem

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mina Noshy Baskales

CONTACT

201126743927mina.baskales@gmail.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

October 12, 2024

First Posted

October 15, 2024

Study Start

October 1, 2024

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

October 15, 2024

Record last verified: 2024-10